Ramatroban (INN) is a thromboxane receptor antagonist.It is also a CRTH2 antagonist.It is indicated for the treatment of coronary artery disease. It has also been used for the treatment of asthma.It was developed by the German pharmaceutical company Bayer AG and is co-marketed in Japan by Bayer and Nippon Shinyaku Co. Ltd. under the tradename Baynas.
This page contains content from the copyrighted Wikipedia article "Ramatroban"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
